• Profile
Close

Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs

The Journal of Infectious Diseases Sep 24, 2021

Ward KM, Falade-Nwulia O, Moon J, et al. - Despite poor adherence and substance use disorders (SUDs), treatment persistence resulted in high sustained virologic response (SVR) rates among HIV/HCV (hepatitis C virus) patients.

  • One hundred ten of the 144 participants with HIV/HCV and SUDs began a 12-week treatment course under one of three conditions (usual care, peer mentors, and cash incentives).

  • The majority of individuals (n = 105) continued treatment once it was initiated, with 95% (n = 100) reaching SVR.

  • By the biomarker phosphatidylethanol (PEth ≥ 50 ng/mL), one-third (34%) of patients reported moderate/heavy alcohol use, and 44% had urine toxicological positive for cocaine or heroin at recruitment.

  • The proportion of people with strong adherence was 72% (n = 76), while the number of people with low adherence was 28%.

  • Despite the fact that low adherence was related to moderate/heavy alcohol use by PEth, SVR did not differ according to adherence (p = 0.702), and the majority of individuals (97%) with low adherence attained SVR.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay